Compounds > tyloxapol
Page last updated: 2024-08-25

tyloxapol and bezafibrate

tyloxapol has been researched along with bezafibrate in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ikeda, S; Kusama, H; Nishiyama, M1
Friedman, M; Gilhar, D; Hoffman, A; Lomnicky, Y; Luria, MH1
Al-Hiari, Y; Al-Qirim, T; El-Huneidi, W; Shahwan, M; Shattat, G; Sweidan, K1
Al-Hiari, Y; Al-Qirim, R; Al-Qirim, T; El-Huneidi, W; Shahwan, M; Shattat, G; Sheikha, GA1
Al-Hiari, Y; Al-Qirim, T; El-Huneidi, W; Hikmat, S; Shattat, G; Sheikha, GA1
Abu Khalaf, R; Abu Sheikha, G; Al-Qirim, T; El-Huneidi, W; Hikmat, S; Shattat, G; Sweidan, K1

Other Studies

6 other study(ies) available for tyloxapol and bezafibrate

ArticleYear
[Pharmacological investigation of bezafibrate, a hypolipidemic agent (1). Effects of bezafibrate on normal and experimental hyperlipidemia in rats].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1988, Volume: 92, Issue:3

    Topics: Administration, Oral; Animals; Bezafibrate; Cholesterol, Dietary; Depression, Chemical; Fructose; Hyperlipidemias; Male; Polyethylene Glycols; Rats; Triglycerides

1988
Improved lipid lowering activity of bezafibrate following continuous gastrointestinal administration: pharmacodynamic rationale for sustained release preparation of the drug.
    Pharmaceutical research, 1999, Volume: 16, Issue:7

    Topics: Animals; Bezafibrate; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Delayed-Action Preparations; Disease Models, Animal; Drug Administration Routes; Duodenum; Enzyme Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Lipase; Lipids; Lipoproteins, HDL; Male; Polyethylene Glycols; Rats; Rats, Inbred Lew; Surface-Active Agents

1999
The hypolipidemic activity of novel benzofuran-2-carboxamide derivatives in Triton WR-1339-induced hyperlipidemic rats: a comparison with bezafibrate.
    Journal of enzyme inhibition and medicinal chemistry, 2010, Volume: 25, Issue:6

    Topics: Animals; Anthracenes; Atherosclerosis; Benzofurans; Bezafibrate; Cholesterol; Cholesterol, HDL; Detergents; Drug Design; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Molecular Structure; Polyethylene Glycols; Random Allocation; Rats; Rats, Wistar; Time Factors; Triglycerides

2010
Synthesis and anti-hyperlipidemic evaluation of N‑(benzoylphenyl)-5-fluoro-1H-indole-2-carboxamide derivatives in Triton WR-1339-induced hyperlipidemic rats.
    Molecules (Basel, Switzerland), 2010, Aug-26, Volume: 15, Issue:9

    Topics: Animals; Bezafibrate; Cholesterol, HDL; Hyperlipidemias; Hypolipidemic Agents; Indoles; Male; Polyethylene Glycols; Rats; Rats, Wistar; Structure-Activity Relationship

2010
Antihyperlipidemic properties of novel N-(benzoylphenyl)-5-substituted-1H-indole-2-carboxamides in Triton WR-1339-induced hyperlipidemic rats.
    Molecules (Basel, Switzerland), 2011, Sep-29, Volume: 16, Issue:10

    Topics: Animals; Bezafibrate; Cholesterol, HDL; Hyperlipidemias; Hypolipidemic Agents; Indoles; Male; Polyethylene Glycols; Rats; Rats, Wistar; Triglycerides

2011
In vivo antihyperlipidemic activity of a new series of N-(benzoylphenyl) and N-(acetylphenyl)-1-benzofuran-2-carboxamides in rats.
    Archiv der Pharmazie, 2012, Volume: 345, Issue:5

    Topics: Animals; Benzofurans; Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Hypolipidemic Agents; Male; Polyethylene Glycols; Rats; Rats, Wistar; Structure-Activity Relationship; Triglycerides

2012